Page results
-
Two clinicians with close links to UCLH and UCL have been appointed to be National Clinical Directors (NCD) by NHS England (NHSE) for 2024.
-
Pop-up clinics in Islington will make it easier for people who are eligible for the Covid-19 vaccine – especially those who are elderly, homeless, vulnerable or in need of support – to get it closer to home.
-
This leaflet provides information about the investigation of and surgery to treat cancer of the oesophagus.
-
UCLH is contributing to a national priority trial of the drug ruxolitinib in patients with Covid-19 pneumonia (infection of the lungs).
-
Experts from across the world, led by UCLH and UCL clinicians and scientists, have created a framework to guide the introduction of new and advanced robots for surgical procedures.
-
The earliest brain changes due to Huntington’s disease can be detected 24 years before clinical symptoms show, according to a new UCL-led study.
-
Professor Karl Peggs has been appointed as UCLH director of research and director of the National Institute for Health and Care Research (NIHR) UCLH Biomedical Research Centre (BRC).
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The stroke team at the National Hospital for Neurology and Neurosurgery (NHNN) is the first in the NHS to carry out implants on cryptogenic stroke patients rather than refer them to a cardiology service.
-
As photographer Tom Pilston searched for a way to make his contribution during the Covid-19 pandemic, he cast around for a project which would allow him to pay tribute to the NHS he describes as "all that is good about the UK ... humane and caring, hard-working, sensitive and strong".
File results
-
FOI/2022/0551 - Procurement contact details
-
FOI/2022/0555 - Senior staff contact details
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0542 - Infection control audits from September 2020 to April 2021
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0559 - Proton Beam Therapy contract
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology